Jing Shan

Jing (Jenny) Shan is a seasoned professional in the biopharmaceutical industry with extensive experience in biologics research and development. Currently serving as Vice President of External R&D Biologics at Curie.Bio, Jing (Jenny) Shan has previously held senior leadership roles in translational research, biologics discovery, and external biologics at Apogee Therapeutics, EQRx, and The Janssen Pharmaceutical Companies of Johnson & Johnson. Additionally, Jing (Jenny) Shan has a background as a Principal Scientist in the New Venture Lab at Moderna, showcasing a strong commitment to advancing biologics innovation.